Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The EPI.FAT.IN Study
NCT03360981Phase 4Completed
- Sponsor
- University of Campania Luigi Vanvitelli
- Start
- Sep 2017
- Primary completion
- Nov 2017
- Countries
- 1
01
Overview
Phase 4 trial in coronary artery disease (CAD) and diabetes mellitus (DM) (3 arms), sponsored by University of Campania Luigi Vanvitelli. Primary endpoints: All cause mortality at 12 months, Cardiac mortality at 12 months and 1 more. Started Sep 2017; status: completed.
02
Conditions
coronary artery disease (CAD)diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT03360981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03360981.